FDA Inspection 1048973 — Optum Compounding Services, LLC

Optum Compounding Services, LLC — FEI 3012890460

The FDA completed an inspection of Optum Compounding Services, LLC on Apr 20, 2018 in Phoenix, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
18008FDCA 503B(a)(10)Drug product label, outsourcer facility
434221 CFR 211.142(b)Storage under appropriate conditions

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.